Abstract
Chemotherapy-induced alopecia (CIA) is a distressing consequence of chemotherapy, with up to 14% of patients at risk of rejecting curative cancer therapies because of the fear of hair loss.1 Although the senior authors (J.S. and K.L.) regularly care for patients with CIA upon completion of their cancer treatment, they rarely have the opportunity to counsel patients before chemotherapy induction. This is in contrast to dermatologists’ frequent involvement in preventing other dermatologic toxicities of anticancer therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
